Results 181 to 190 of about 272,512 (195)

MYCN amplification affects neuroblastoma survival

Nature Reviews Neurology, 2014
openaire   +1 more source

Comprehensive evaluation of context dependence of the prognostic impact of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project

Pediatric Blood and Cancer, 2019
Katherine Matthay, Adela Canete, Garrett M Brodeur   +2 more
exaly  

Detection of MYCN amplification using blood plasma: noninvasive therapy evaluation and prediction of prognosis in neuroblastoma

Pediatric Surgery International, 2013
Eiso Hiyama, Masato Kojima, Yoshiyuki Onitake   +2 more
exaly  

Implications of MYCN amplification in patients with stage 4 neuroblastoma who undergo intensive chemotherapy

Journal of Pediatric Surgery, 2007
Sachiyo Suita, Michio Kaneko, Yoshiaki Tsuchida   +2 more
exaly  

Intratumoural heterogeneity of 1p deletions andMYCN amplification in neuroblastomas

Medical and Pediatric Oncology, 2001
Peter F Ambros
exaly  

Clinical significance of MYCN amplification in patients with high‐risk neuroblastoma

Pediatric Blood and Cancer, 2018
Ki Woong Sung, Hee Young Ju, Hong Hoe Koo   +2 more
exaly  

Neuroblastomas with Discordant Genotype-Phenotype Relationships: Report of Four Cases with MYCN Amplification and Favorable Histology

Pediatric and Developmental Pathology, 2011
Kentaro Matsuoka, Atsuko Nakagawa
exaly  

Influence of neuroblastoma stage on serum‐based detection of MYCN amplification

Pediatric Blood and Cancer, 2009
Alain Puisieux, Wendy B London
exaly  

Correlation between the number of segmental chromosome aberrations and the age at diagnosis of diploid neuroblastomas without MYCN amplification

Journal of Pediatric Surgery, 2011
Yoshinao Oda, Kenichi Kohashi, Risa Teshiba   +2 more
exaly  

WT1 expression is inversely correlated with MYCN amplification or expression and associated with poor survival in non‐MYCN‐amplified neuroblastoma

Molecular Oncology, 2016
Evelyne Ségal-Bendirdjian
exaly